483
Ursa Brown-GlabermanFDA 483 - Ursa Brown-Glaberman - December 19, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Ursa Brown-Glaberman in Albuquerque, NM, identified a significant issue related to clinical trial conduct. The firm failed to promptly report serious adverse events (SAEs) to the study sponsor for multiple participants, indicating a lapse in adherence to protocol requirements for timely safety reporting.
- Office
- Denver District Office
- Person
Open in Dashboard
ID · 6a5ea1a7-b5b6-4265-8f28-45bafe2b0fc2